SCHEMBL2802419

SCHEMBL2802419

CCCCCCCCC#CCCCCCCO

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.68
LMNA P02545 2/20 0.68
MEN1 O00255 2/20 0.68
KMT2A Q03164 2/20 0.68
TSHR P16473 2/20 0.68
HSD17B10 Q99714 1/20 0.68
SMN1; SMN2 Q16637 2/20 0.63
PTPN7 P35236 5/20 0.56
HMGCR P04035 2/20 0.56
RECQL P46063 2/20 0.50
TDP1 Q9NUW8 2/20 0.50
KDM4E B2RXH2 1/20 0.47
USP2 O75604 1/20 0.47
POLB P06746 1/20 0.47
MAPT P10636 1/20 0.47
HPGD P15428 1/20 0.47
ALOX12 P18054 1/20 0.47
BLM P54132 1/20 0.47
MCL1 Q07820 1/20 0.47
SELP P16109 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2075488 1.00 ALDH1A1 (0.68) ALDH1A1LMNAMEN1KMT2ATSHR
SCHEMBL9155902 1.00 ALDH1A1 (0.68) ALDH1A1LMNAMEN1KMT2ATSHR
SCHEMBL11065903 1.00 ALDH1A1 (0.68) ALDH1A1LMNAMEN1KMT2ATSHR
SCHEMBL8907002 1.00 ALDH1A1 (0.68) ALDH1A1LMNAMEN1KMT2ATSHR
SCHEMBL11129684 1.00 ALDH1A1 (0.68) ALDH1A1LMNAMEN1KMT2ATSHR
SCHEMBL7121183 1.00 ALDH1A1 (0.68) ALDH1A1LMNAMEN1KMT2ATSHR
SCHEMBL8027862 1.00 ALDH1A1 (0.68) ALDH1A1LMNAMEN1KMT2ATSHR
SCHEMBL21411191 1.00 ALDH1A1 (0.68) ALDH1A1LMNAMEN1KMT2ATSHR
SCHEMBL20991348 1.00 ALDH1A1 (0.68) ALDH1A1LMNAMEN1KMT2ATSHR
SCHEMBL11060089 1.00 ALDH1A1 (0.68) ALDH1A1LMNAMEN1KMT2ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260103438-A1 PROBES AND METHODS TO IDENTIFY LIGANDABLE FATTY ACYLATION SITES FOR THERAPEUTIC TARGET IDENTIFICATION MASSACHUSETTS GEN HOSPITAL (US) 2026-04-16 US disclosed
EP-2396418-A1 METHODS FOR THE DETECTION OF FATTY-ACYLATED PROTEINS Genentech, Inc. (US) 2011-12-21 EP disclosed
WO-2010093916-A1 METHODS FOR THE DETECTION OF FATTY-ACYLATED PROTEINS GENENTECH, INC. (US) 2010-08-19 WO disclosed
US-20100189660-A1 METHODS FOR THE DETECTION OF FATTY-ACYLATED PROTEIN GENENTECH, INC. (US) 2010-07-29 US disclosed
US-20100189660-A1 METHODS FOR THE DETECTION OF FATTY-ACYLATED PROTEIN GENENTECH, INC. (US) 2010-07-29 US disclosed
US-7659353-B2 Hyperbranched polymers THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2010-02-09 US disclosed
US-20050164899-A1 Hyperbranched polymers THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2005-07-28 US disclosed
US-20030225232-A1 Hyperbranched polymers HONG KONG UNIVERSITY OF SCIENCE & TECHNOLOGY, THE (HK) 2003-12-04 US disclosed
US-4440940-A HYPOLIPIDEMIC AND ANTIATHEROSCLEROTIC AGENTS AMERICAN CYANAMID COMPANY (US) 1984-04-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100189660-A1 METHODS FOR THE DETECTION OF FATTY-ACYLATED PROTEIN FABP1, DBI, FABP4 ALDH1A1 3098/4885LMNA 380/4885MEN1 4522/4885
US-20260103438-A1 PROBES AND METHODS TO IDENTIFY LIGANDABLE FATTY ACYLATION SITES FOR THERAPEUTIC TARGET IDENTIFICATION ZDHHC2, SPTLC2, SPTLC1 ALDH1A1 558/4885LMNA 4345/4885MEN1 4664/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.